Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents

Chronic obstructive pulmonary disease (COPD) is characterized by progressive airflow limitation and debilitating symptoms. For patients with moderate-to-severe COPD, long-acting bronchodilators are the mainstay of therapy; as symptoms progress, guidelines recommend combining bronchodilators from dif...

Descripción completa

Detalles Bibliográficos
Autores principales: Tashkin, Donald P, Fabbri, Leonardo M
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2991288/
https://www.ncbi.nlm.nih.gov/pubmed/21034447
http://dx.doi.org/10.1186/1465-9921-11-149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2991288/
https://www.ncbi.nlm.nih.gov/pubmed/21034447
http://dx.doi.org/10.1186/1465-9921-11-149

Ejemplares similares